Cresco Labs (CRLBF) Depreciation & Amortization (IS) (2019 - 2026)
Cresco Labs (CRLBF) reported Depreciation & Amortization (IS) of $4.9 million for Q1 2026, down 61.89% on a YoY basis from $12.9 million in Q1 2025, and down 0.95% quarter-over-quarter from $5.0 million in Q4 2025.
Cresco Labs (CRLBF) Depreciation & Amortization (IS) (2019 - 2026) Analysis & Trends
Cresco Labs has reported Depreciation & Amortization (IS) for 8 years, with the latest figure at $4.9 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (IS) fell 61.89% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (down 31.83% YoY), and the FY2025 full-year result was $5.0 million, down 77.19% from the prior year.
- Depreciation & Amortization (IS) for Q1 2026 stood at $4.9 million, down from $5.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (IS) was $12.9 million in Q1 2025, with the low at $4.3 million in Q1 2023.
- Historically, Depreciation & Amortization (IS) has averaged $6.2 million across 5 years, with a median of $5.5 million in 2024.
- Annual changes were most pronounced in 2025 — Depreciation & Amortization (IS) surged 138.03% — and 2026, when it tumbled 61.89%.
- Cresco Labs' Depreciation & Amortization (IS) stood at $6.0 million in 2022, then jumped by 65.86% to $10.0 million in 2023, then plunged by 45.31% to $5.5 million in 2024, then declined by 9.0% to $5.0 million in 2025, then decreased by 0.95% to $4.9 million in 2026.
- The last three Depreciation & Amortization (IS) figures came in at $4.9 million (Q1 2026), $5.0 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 1.88 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Cresco Labs | - | - | 75.45 Mn | 4.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 4.42 Mn |
| Mar 31, 2025 | 12.91 Mn |
| Dec 31, 2024 | 5.46 Mn |
| Sep 30, 2024 | 5.70 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Dec 31, 2023 | 9.98 Mn |
| Sep 30, 2023 | 5.94 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.27 Mn |
| Dec 31, 2022 | 6.02 Mn |
| Sep 30, 2022 | 4.42 Mn |
| Jun 30, 2022 | 5.65 Mn |
| Mar 31, 2022 | 10.96 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | 5.79 Mn |
| Jun 30, 2021 | 5.69 Mn |